WO2025114605 - ANTI-SEIZURE COMBINATION THERAPY
National phase entry is expected:
Publication Number
WO/2025/114605
Publication Date
05.06.2025
International Application No.
PCT/EP2024/084345
International Filing Date
02.12.2024
Title **
[English]
ANTI-SEIZURE COMBINATION THERAPY
[French]
POLYTHÉRAPIE CONTRE LES CRISES D'ÉPILEPSIE
Applicants **
KATHOLIEKE UNIVERSITEIT LEUVEN
Inventors
CAMMUE, Bruno
DE WITTE, Peter
LAGAE, Lieven
NY, Annelii
THEVISSEN, Karin
Priority Data
23213736.4
01.12.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1882 | |
| EPO | Filing, Examination, Granting | 8131 | |
| Japan | Filing, Examination, Granting | 2006 | |
| South Korea | Filing, Examination, Granting | 1747 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
18,506
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The invention relates a composition comprising clioquinol and idebenone as active ingredients for use in treating or preventing of a seizure in epilepsy.[French]
L'invention concerne une composition contenant du clioquinol et de l'idébénone en tant que principes actifs destinée à être utilisée dans le traitement ou la prévention d'une crise d'épilepsie.